Synergistic Embolic Capture System for Enhanced Treatment Outcomes

Publication ID: 24-11857209_0008_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Embolic Capture System for Enhanced Treatment Outcomes,” Published Technical Disclosure No. 24-11857209_0008_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857209_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,209.

Summary of the Inventive Concept

A novel, integrated system for treating blocked blood vessels by combining catheter-based emboli removal with AI, IoT, blockchain, and new materials to enhance treatment efficacy, patient safety, and data management.

Background and Problem Solved

Current mechanical thrombectomy devices have limitations in terms of real-time visualization, data tracking, and personalized treatment. The present inventive concept addresses these limitations by integrating distinct technologies to create a more powerful system for treating blocked blood vessels.

Detailed Description of the Inventive Concept

The synergistic embolic capture system comprises a catheter-based emboli removal system, an AI-powered imaging module for real-time visualization of the vasculature, IoT sensors to monitor blood flow and pressure, a blockchain-based data storage system for tracking treatment outcomes, and new material-based coatings for enhanced biocompatibility. The system enables real-time embolic capture monitoring, personalized thrombectomy, and secure patient data management. The AI-powered predictive model optimizes treatment by integrating data from IoT sensors, and the blockchain-based data storage system ensures secure and transparent tracking of treatment outcomes.

Novelty and Inventive Step

The new claims introduce a synergistic combination of distinct technologies, including AI, IoT, blockchain, and new materials, to create a more powerful system for treating blocked blood vessels. This integration of technologies provides a non-obvious solution to the limitations of current mechanical thrombectomy devices.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include variations in the AI-powered predictive model, IoT sensor configurations, blockchain-based data storage systems, and new material-based coatings. Additionally, the system could be adapted for use in other vascular systems, such as coronary or peripheral vessels.

Potential Commercial Applications and Market

The synergistic embolic capture system has significant commercial potential in the medical device industry, particularly in the areas of neurointerventional and cardiovascular treatment. The system's ability to enhance treatment outcomes, patient safety, and data management makes it an attractive solution for hospitals, clinics, and medical research institutions.

CPC Classifications

SectionClassGroup
A A61 A61B17/22012
A A61 A61B17/221
A A61 A61B2017/22038
A A61 A61B2017/22084

Original Patent Information

Patent NumberUS 11,857,209
TitleDevices and methods for treating blocked blood vessels
Assignee(s)SHANGHAI WALLABY MEDICAL TECHNOLOGIES CO., INC.